» Authors » Jeffrey S Taylor

Jeffrey S Taylor

Explore the profile of Jeffrey S Taylor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 247
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Little K, Taylor J, Schlosser M
Healthc Financ Manage . 2018 Jun; 70(11):88-84. PMID: 29897221
No abstract available.
2.
Brown R, Tan D, Taylor J, Miller M, Prichard J, Kott M
Ann Clin Lab Sci . 2007 May; 37(2):141-7. PMID: 17522369
Morphoproteomic analysis reveals the constitutive activation of the mTOR, ERK, and NF-kappaB pathways in high risk neuroblastoma (HRN) cases as evidenced by (a) collective commonalities of: phosphorylated (p)-mTOR, p70S6K, ERK...
3.
Taylor J, Reid T, Terry K, Casey P, Beese L
EMBO J . 2003 Nov; 22(22):5963-74. PMID: 14609943
Protein geranylgeranyltransferase type-I (GGTase-I), one of two CaaX prenyltransferases, is an essential enzyme in eukaryotes. GGTase-I catalyzes C-terminal lipidation of >100 proteins, including many GTP- binding regulatory proteins. We present...
4.
deSolms S, Ciccarone T, MacTough S, Shaw A, Buser C, Ellis-Hutchings M, et al.
J Med Chem . 2003 Jun; 46(14):2973-84. PMID: 12825937
A series of novel diaryl ether lactams have been identified as very potent dual inhibitors of protein farnesyltransferase (FTase) and protein geranylgeranyltransferase I (GGTase-I), enzymes involved in the prenylation of...
5.
Johnson S, Taylor J, Beese L
Proc Natl Acad Sci U S A . 2003 Mar; 100(7):3895-900. PMID: 12649320
DNA polymerases replicate DNA by adding nucleotides to a growing primer strand while avoiding frameshift and point mutations. Here we present a series of up to six successive replication events...
6.
Bell I, Gallicchio S, Abrams M, Beese L, Beshore D, Bhimnathwala H, et al.
J Med Chem . 2002 May; 45(12):2388-409. PMID: 12036349
A series of macrocyclic 3-aminopyrrolidinone farnesyltransferase inhibitors (FTIs) has been synthesized. Compared with previously described linear 3-aminopyrrolidinone FTIs such as compound 1, macrocycles such as 49 combined improved pharmacokinetic properties...